Healthpeak Properties (DOC) Q2 2025 earnings summary

Executive summary

• Delivered strong Q2 2025 financial and operational results, with robust performance across core business segments and continued execution of strategic initiatives.

• Portfolio includes 702 properties across outpatient medical, lab, and CCRC segments as of June 30, 2025, with a focus on high-quality healthcare real estate and a diversified asset base.

• Completed a major merger with Physicians Realty Trust in March 2024, adding 299 outpatient medical buildings and expanding scale and diversification.

• Completed a major technology upgrade to enhance data integration, productivity, and AI deployment capabilities.

• Internalized property management in key markets, improving tenant relationships and satisfaction, and driving high retention and leasing spreads.

Financial highlights

• Q2 2025 FFO as Adjusted: $0.46 per share; AFFO: $0.44 per share; net income: $0.05 per share.

• Total revenues for Q2 2025 were $694 million, nearly flat compared to $695 million in Q2 2024.

• Total portfolio same-store growth: 3.5% year-over-year.

• CCRC same-store growth: 8.6%, driven by 5% rate growth and higher entrance fee sales.

• Outpatient medical same-store cash NOI growth: 3.9%; tenant retention: 85%; positive rent mark-to-market: 6%.

Outlook and guidance

• Reaffirmed full-year 2025 FFO as Adjusted guidance of $1.81–$1.87 per share.

• CCRC portfolio on track to exceed high end of segment guidance with 12% YTD same-store growth.

• Outpatient medical expected to reach high end of initial segment guidance, supported by strong leasing pipeline.

• Life science segment faces near-term occupancy headwinds but has upside potential if capital markets improve.

• Management expects cash flows from operations, available cash, and financing activities to be adequate for the next 12 months and foreseeable future.